Aspen Aerogels Q3 revenue drops 38%, adjusted EPS misses

Aspen Aerogels

06/11/2025 11:41

Overview

Aspen Aerogels Q3 2025 revenue fell to $73 mln from $117.3 mln in Q3 2024

Adjusted EPS for Q3 2025 missed analyst expectations

Net loss for Q3 2025 improved to $6.3 mln from $13 mln in Q3 2024

Outlook

Aspen lowers 2025 revenue outlook to $270-280 mln from $297-317 mln

Company revises 2025 adjusted EBITDA forecast to $7-15 mln from $35-45 mln

Aspen anticipates Energy Industrial growth in 2026 from LNG and Subsea projects

Result Drivers

EV MARKET CHALLENGES - Lower near-term EV production in North America impacted revenue, per CEO Don Young

EU OEM AWARD - PyroThin® contract from major EU OEM supports growth opportunities, per CEO Don Young

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Adjusted EPS
Miss
-$0.06
-$0.03 (6 Analysts)
Q3 EPS
-$0.08
Q3 Net Income
-$6.30 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the specialty chemicals peer group is "buy"

Wall Street's median 12-month price target for Aspen Aerogels Inc is $9.50, about 22% above its November 5 closing price of $7.41

Press Release: ID:nGNX1kR39W

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)